These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19836370)

  • 21. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
    Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease.
    Giovannini MG; Cerbai F; Bellucci A; Melani C; Grossi C; Bartolozzi C; Nosi D; Casamenti F
    Neuroscience; 2008 May; 153(3):618-33. PubMed ID: 18406062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease.
    Pugh PL; Richardson JC; Bate ST; Upton N; Sunter D
    Behav Brain Res; 2007 Mar; 178(1):18-28. PubMed ID: 17229472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
    Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
    Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plaques, tangles, and memory loss in mouse models of neurodegeneration.
    Eriksen JL; Janus CG
    Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wheel-running in a transgenic mouse model of Alzheimer's disease: protection or symptom?
    Richter H; Ambrée O; Lewejohann L; Herring A; Keyvani K; Paulus W; Palme R; Touma C; Schäbitz WR; Sachser N
    Behav Brain Res; 2008 Jun; 190(1):74-84. PubMed ID: 18342378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease selective vulnerability and modeling in transgenic mice.
    Götz J; Schonrock N; Vissel B; Ittner LM
    J Alzheimers Dis; 2009; 18(2):243-51. PubMed ID: 19584440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues.
    Obulesu M; Rao DM
    Int J Neurosci; 2010 Aug; 120(8):531-7. PubMed ID: 20615056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Animal model for Alzheimer's disease].
    Takashima A; Chui D
    Nihon Rinsho; 2004 Apr; 62 Suppl 4():240-7. PubMed ID: 15174678
    [No Abstract]   [Full Text] [Related]  

  • 33. Transgenic mouse models of Alzheimer's disease.
    Elder GA; Gama Sosa MA; De Gasperi R
    Mt Sinai J Med; 2010; 77(1):69-81. PubMed ID: 20101721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease: old problem, new views from transgenic and viral models.
    Jaworski T; Dewachter I; Seymour CM; Borghgraef P; Devijver H; Kügler S; Van Leuven F
    Biochim Biophys Acta; 2010 Oct; 1802(10):808-18. PubMed ID: 20332023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
    Sabbagh JJ; Kinney JW; Cummings JL
    Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?
    Zahs KR; Ashe KH
    Trends Neurosci; 2010 Aug; 33(8):381-9. PubMed ID: 20542579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease modeling: ups, downs, and perspectives for human induced pluripotent stem cells.
    Wojda U; Kuznicki J
    J Alzheimers Dis; 2013; 34(3):563-88. PubMed ID: 23313930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic animals as models of neurodegenerative diseases in humans.
    Theuring F; Thunecke M; Kosciessa U; Turner JD
    Trends Biotechnol; 1997 Aug; 15(8):320-5. PubMed ID: 9263480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Melatonin agonist: a possible disease-modifying agent for Alzheimer's disease].
    Matsubara E
    Nihon Rinsho; 2012 Feb; 70(2):349-52. PubMed ID: 22413544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease. Mouse model made.
    Duff K; Hardy J
    Nature; 1995 Feb; 373(6514):476-7. PubMed ID: 7845455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.